Active Smokers Are at Higher Risk of COVID-19 Death: A Systematic Review and Meta-analysis

被引:25
|
作者
Patanavanich, Roengrudee [1 ]
Siripoon, Tanatorn [1 ]
Amponnavarat, Salin [1 ]
Glantz, Stanton A. [2 ]
机构
[1] Mahidol Univ, Fac Med, Dept Community Med, Ramathibodi Hosp, 270 Rama VI Rd, Bangkok 10400, Thailand
[2] Univ Calif San Francisco, Ctr Tobacco Control Res & Educ, San Francisco, CA 94143 USA
关键词
MORTALITY; SMOKING; MULTICENTER; PREVALENCE; SEVERITY; EXPOSURE; FRAILTY; TOBACCO; HEALTH; IMPACT;
D O I
10.1093/ntr/ntac085
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
Introduction Current evidence indicates that smoking worsens COVID-19 outcomes. However, when studies restricted their analyses to current smokers, the risks for COVID-19 severity and death are inconsistent. Aims and Methods This meta-analysis explored the association between current smoking and the risk for mortality based on the studies that reported all three categories of smoking (current, former, and never smokers) to overcome the limitation of the previous meta-analyses which former smokers might have been classified as nonsmokers. We searched PubMed and Embase up to January 1, 2021. We included studies reporting all three categories of smoking behaviors of COVID-19 patients and mortality outcomes. A random-effects meta-analysis and meta-regression were used to examine relationships in the data. Results A total of 34 articles with 35 193 COVID-19 patients was included. The meta-analysis confirmed the association between current smoking (odds ratio [OR] 1.26, 95% confidence interval [CI]: 1.01-1.58) and former smoking (OR 1.76, 95% CI: 1.53-2.03) with COVID-19 mortality. We also found that the risk for COVID-19 death in current smokers does not vary by age, but significantly drops by age in former smokers. Moreover, current smokers in non-high-income countries have higher risks of COVID-19 death compared with high-income countries (OR 3.11, 95% CI: 2.04-4.72 vs. OR 1.14, 95% CI: 0.91-1.43; p = .015). Conclusions Current and former smokers are at higher risk of dying from COVID-19. Tobacco control should be strengthened to encourage current smokers to quit and prevent the initiation of smoking. Public health professionals should take the COVID-19 pandemic as an opportunity to promote smoking prevention and cession. Implications This study makes an important contribution to the existing literature by distinguishing between current and former smoking and their separate effects on COVID-19 mortality. We also explore the effects by age of patients and country income level. Findings from this study provide empirical evidence against misinformation about the relationship between smoking and COVID-19 mortality.
引用
收藏
页码:177 / 184
页数:8
相关论文
共 50 条
  • [41] Higher risk of death in COVID-19 patients complicated by gastrointestinal bleeding events: a meta-analysis
    Zuin, Marco
    Rigatelli, Gianluca
    Fogato, Luisella
    Zuliani, Giovanni
    Roncon, Loris
    [J]. MINERVA GASTROENTEROLOGY, 2021, 67 (04): : 408 - 410
  • [42] Efficacy of tocilizumab in COVID-19: A systematic review and meta-analysis
    Aziz, Muhammad
    Haghbin, Hossein
    Abu Sitta, Emad
    Nawras, Yusuf
    Fatima, Rawish
    Sharma, Sachit
    Lee-Smith, Wade
    Duggan, Joan
    Kammeyer, Joel A.
    Hanrahan, Jennifer
    Assaly, Ragheb
    [J]. JOURNAL OF MEDICAL VIROLOGY, 2021, 93 (03) : 1620 - 1630
  • [43] Epidemiological characteristics of COVID-19: a systematic review and meta-analysis
    Khalili, Malahat
    Karamouzian, Mohammad
    Nasiri, Naser
    Javadi, Sara
    Mirzazadeh, Ali
    Sharifi, Hamid
    [J]. EPIDEMIOLOGY AND INFECTION, 2020, 148
  • [44] COVID-19 and Pregnancy Complications: Meta-analysis and Systematic Review
    Gokce, Sefik
    Herkiloglu, Dilsad
    [J]. CURRENT WOMENS HEALTH REVIEWS, 2024, 20 (03)
  • [45] Corticosteroids in COVID-19: Is it Rational? A Systematic Review and Meta-Analysis
    Pravash Budhathoki
    Dhan Bahadur Shrestha
    Era Rawal
    Sitaram Khadka
    [J]. SN Comprehensive Clinical Medicine, 2020, 2 (12) : 2600 - 2620
  • [46] COVID-19 in pregnant women: A systematic review and meta-analysis
    Capobianco, Giampiero
    Saderi, Laura
    Aliberti, Stefano
    Mondoni, Michele
    Piana, Andrea
    Dessole, Francesco
    Dessole, Margherita
    Cherchi, Pier Luigi
    Dessole, Salvatore
    Sotgiu, Giovanni
    [J]. EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2020, 252 : 543 - 558
  • [47] A systematic review and meta-analysis on correlation of weather with COVID-19
    Poulami Majumder
    Partha Pratim Ray
    [J]. Scientific Reports, 11
  • [48] A systematic review and meta-analysis of obesity and COVID-19 outcomes
    Xinya Zhang
    Alexander M. Lewis
    John R. Moley
    Jonathan R. Brestoff
    [J]. Scientific Reports, 11
  • [49] Tocilizumab for severe COVID-19: a systematic review and meta-analysis
    Lan, Shao-Huan
    Lai, Chih-Cheng
    Huang, Hui-Ting
    Chang, Shen-Peng
    Lu, Li-Chin
    Hsueh, Po-Ren
    [J]. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 56 (03)
  • [50] Heterogeneity and Risk of Bias in Studies Examining Risk Factors for Severe Illness and Death in COVID-19: A Systematic Review and Meta-Analysis
    Degarege, Abraham
    Naveed, Zaeema
    Kabayundo, Josiane
    Brett-Major, David
    [J]. PATHOGENS, 2022, 11 (05):